Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious ‘techbio’ company positions itself for its next phase of AI ...

Recursion Pharmaceuticals ( ($RXRX) ) has provided an update. Recursion Pharmaceuticals announced significant leadership changes effective January ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Decentralized finance platform Stream Finance says it has paused deposits and withdrawals after an external fund manager ...

Abstract: An efficient selection of indexes is indispensable for database performance. For large problem instances with hundreds of tables, existing approaches are not suitable: They either exhibit ...

When I introduced Steven Pinker, it felt like our worldviews couldn't have been more different. Here's why that dissonance was exactly the point.

Abstract: Event cameras are bio-inspired vision sensors that mimic retinas to asynchronously report per-pixel intensity changes rather than outputting an actual intensity image at regular intervals.

For years, privacy-focused blockchains were seen as side projects with limited reach. That’s about to change with Zero Knowledge Proof (ZKP). Built as a privacy ...

It's a plot device beloved by science fiction: our entire universe might be a simulation running on some advanced ...